These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10698276)

  • 21. Thrombin inhibits apoptosis of monocytes and plasminogen activator inhibitor 2 (PAI-2) is not responsible for this inhibition.
    Ritchie H; Fragoyannis A
    Exp Cell Res; 2000 Oct; 260(1):20-9. PubMed ID: 11010807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen activator inhibitor-1 increases the expression of VEGF in human glioma cells.
    Hjortland GO; Lillehammer T; Somme S; Wang J; Halvorsen T; Juell S; Hirschberg H; Fodstad Ø; Engebraaten O
    Exp Cell Res; 2004 Mar; 294(1):130-9. PubMed ID: 14980508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cytotoxicity of anti-PAI-1 oligonucleotides and their conjugates.
    Kobylańska A; Pluskota E; Pawłowska Z; Okruszek A; Cierniewski CS; Stec WJ
    Nucleosides Nucleotides; 1999; 18(6-7):1709-10. PubMed ID: 10474252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor receptor-2-induced initial endothelial cell migration depends on the presence of the urokinase receptor.
    Prager GW; Breuss JM; Steurer S; Olcaydu D; Mihaly J; Brunner PM; Stockinger H; Binder BR
    Circ Res; 2004 Jun; 94(12):1562-70. PubMed ID: 15131009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition by modified oligodeoxynucleotides of the expression of type-1 plasminogen activator inhibitor in human endothelial cells.
    Cierniewski CS; Babinska A; Swiatkowska M; Wilczynska M; Okruszek A; Stec WJ
    Eur J Biochem; 1995 Jan; 227(1-2):494-9. PubMed ID: 7851428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereodependent inhibition of plasminogen activator inhibitor type 1 by phosphorothioate oligonucleotides: proof of sequence specificity in cell culture and in vivo rat experiments.
    Stec WJ; Cierniewski CS; Okruszek A; Kobylańska A; Pawłowska Z; Koziołkiewicz M; Pluskota E; Maciaszek A; Rebowska B; Stasiak M
    Antisense Nucleic Acid Drug Dev; 1997 Dec; 7(6):567-73. PubMed ID: 9450914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Internalization of oligodeoxynucleotide antisense to type-1 plasminogen activator inhibitor mRNA in endothelial cells: a three-dimensional reconstruction by confocal microscopy.
    Wyroba E; Pawlowska Z; Kobylanska A; Pluskota E; Maszewska M; Stec WJ; Cierniewski CS
    Biol Cell; 1996; 87(1-2):37-43. PubMed ID: 9004485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of potentially effective antisense oligodeoxyribonucleotide (ODN) sequences for inhibiting plasminogen activator inhibitor-2 (PAI-2) production by monocytes.
    Humphries J; Burnand KG; Cunningham P; Brock A; Westwood N; Smith A
    Thromb Haemost; 2002 Jul; 88(1):131-6. PubMed ID: 12152653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents.
    Muldowney JA; Stringham JR; Levy SE; Gleaves LA; Eren M; Piana RN; Vaughan DE
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):400-6. PubMed ID: 17158352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of PAI-1 concentration in platelets by systemic administration of antisense oligonucleotides to rats.
    Pawlowska Z; Chabielska E; Kobylanska A; Maciaszek A; Swiatkowska M; Buczko W; Stec WJ; Cierniewski CS
    Thromb Haemost; 2001 Jun; 85(6):1086-9. PubMed ID: 11434689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) for effective antisense formation.
    Morita K; Yamate K; Kurakata S; Watanabe K; Imanishi T; Koizumi M
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1619-21. PubMed ID: 14565480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidised-HDL3 induces the expression of PAI-1 in human endothelial cells. Role of p38MAPK activation and mRNA stabilization.
    Norata GD; Banfi C; Pirillo A; Tremoli E; Hamsten A; Catapano AL; Eriksson P
    Br J Haematol; 2004 Oct; 127(1):97-104. PubMed ID: 15384983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.
    Chorostowska-Wynimko J; Swiercz R; Skrzypczak-Jankun E; Selman SH; Jankun J
    Oncol Rep; 2004 Dec; 12(6):1155-62. PubMed ID: 15547731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells.
    Yang DC; Jiang X; Elliott RL; Head JF
    Anticancer Res; 2002; 22(3):1513-24. PubMed ID: 12168831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line.
    Takeshita Y; Takamura T; Hamaguchi E; Shimizu A; Ota T; Sakurai M; Kaneko S
    Metabolism; 2006 Nov; 55(11):1464-72. PubMed ID: 17046548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of heat shock factor-1 in glycated LDL-induced upregulation of plasminogen activator inhibitor-1 in vascular endothelial cells.
    Zhao R; Shen GX
    Diabetes; 2007 May; 56(5):1436-44. PubMed ID: 17259369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasminogen activator inhibitor-1 mRNA expression in cultured pigmented ciliary epithelial cells of the porcine eye.
    Meyer MW; von Depka M; Wilhelm C; Schröder A; Erb C
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):679-86. PubMed ID: 12192463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
    Liang X; Kanjanabuch T; Mao SL; Hao CM; Tang YW; Declerck PJ; Hasty AH; Wasserman DH; Fogo AB; Ma LJ
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E103-E113. PubMed ID: 16144810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.